(Q34323538)

English

Probabilistic cost-effectiveness analysis of HIV prevention. Comparing a Bayesian approach with traditional deterministic sensitivity analysis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

Probabilistic cost-effectiveness analysis of HIV prevention. Comparing a Bayesian approach with traditional deterministic sensitivity analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

prevention of HIV/AIDS

0 references

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

author name string

A P Johnson-Masotti

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

P W Laud

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

R G Hoffmann

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

M J Hayat

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

S D Pinkerton

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Evaluation Review

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

474-502

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Physical activity, physical fitness, and risk of dying.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Assortative sexual mixing in a heterosexual clinic population--a limiting factor in HIV spread?

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

The CE plane: a graphic representation of cost-effectiveness.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

The cost-effectiveness of preventing AIDS-related opportunistic infections

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Bayesian estimation of cost-effectiveness ratios from clinical trials.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Cost-effectiveness of an HIV risk reduction intervention for adults with severe mental illness.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Statistical inference for cost-effectiveness ratios.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Building uncertainty into cost-effectiveness rankings: portfolio risk-return tradeoffs and implications for decision rules

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Effectiveness of condoms in preventing HIV transmission

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Secondary HIV transmission rates in a mixed-gender sample

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Cost-threshold analyses of the National AIDS Demonstration Research HIV prevention interventions.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Cost-effectiveness of a community-level HIV risk reduction intervention.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Model-based evaluation of HIV prevention interventions

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Cost-effectiveness of HIV-prevention skills training for men who have sex with men.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Markov models in medical decision making: a practical guide.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Probabilistic analysis of decision trees using symbolic algebra.

1 reference

https://api.crossref.org/works/10.1177%2F0193841X0102500404

21 January 2018

Identifiers

10.1177/0193841X0102500404

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34323538&oldid=2038941512"